Antimicrobial Susceptibility Testing Market

Antimicrobial Susceptibility Testing Market worth $5.68 Billion by 2029

The report "Antimicrobial Susceptibility Testing Market by Product (Manual (Disk, Strip, Plate), Automated, Molecular), Method (e-test, Disk & Agar Diffusion, Genotypic), Type (Antibacterial, Antifungal), Application (Clinical, Epidemiology) Global Forecasts to 2029", is expected to grow from USD 4.45 billion in 2024 to USD 5.68 billion in 2029, at a CAGR of 5.0% over the forecast period. Increasing antimicrobial resistance worldwide has emerged as one of the major challenges to global health. With resistant bacteria now regarded as a significant and deadly threat - because they can develop a measure of resistance to traditional antibiotics, there is a need for more accurate and rapid testing methods to guide appropriate treatment decisions. Additionally, the growing healthcare cost and demand for personalized medicine have also elevated the market growth. In addition, the growing incidence of nosocomial infections due to MDROs has further accelerated the need for advanced testing technologies.

Browse 240 market data Tables and 56 Figures spread through 282 Pages and in-depth TOC on "Antimicrobial Susceptibility Testing Market by Product (Manual (Disk, Strip, Plate), Automated, Molecular), Method (e-test, Disk & Agar Diffusion, Genotypic), Type (Antibacterial, Antifungal), Application (Clinical, Epidemiology) Global Forecasts to 2029"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/antimicrobial-susceptibility-testing-market-206359984.html

Lab instruments segment to register a significant growth rate over the forecast period of 2024-2029.

Laboratory instruments to grow significantly in the AST market. It is further segmented into automated instrument and molecular diagnostics. Automated systems of AST have enormous advantages in terms of efficiency, accuracy, and standardization. These can process great volumes of samples. Automation is therefore giving room for improved turnaround times and laboratory workflows. Applications like PCR and nucleic acid hybridization in molecular diagnostics detect microorganisms and their resistance genes in an extremely rapid and sensitive manner. These technologies for the detection of emerging antibiotic-resistant pathogens thus greatly help guide appropriate treatment decisions. The demand for reliable and effective AST has thus increased, driven partly by both recent demand growth and by the advancement of automated instruments as well as that of molecular diagnostics.

By Application in the Antimicrobial susceptibility testing market in 2023.

The overall market of clinical diagnostics, particularly in the area of AST, is experiencing highest growth rate because of many converging factors. The increasing incidence of infectious diseases with an alarming increase in antibiotic resistance raises the need to diagnose infections and implement appropriate treatment in a prompt and proper manner. Advances in technologies such as automation, rapid diagnostic tests, and molecular diagnostics are bringing earlier detection, faster results, and higher clinical benefits. Additionally, the thrust towards personalized medicine and precision healthcare throws up a higher demand for tailored diagnostic solutions. Secondly, as the segment of the aging population is increasing along with the health problems associated with the same, it contributes further to market growth. All these forces with supportive government policies and increased healthcare spending are catapulting clinical diagnostics, especially AST, into multifold growth in the near future.

North America to account for a significant market share in the Antimicrobial susceptibility testing market in 2023.

The antimicrobial susceptibility testing market, by region: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America was the largest regional market in 2023 North America will continue to dominate the antimicrobial susceptibility testing market owing to various factors. The region has a high incidence of infectious diseases, with better health infrastructure, thereby increasing demand for accurate diagnostic tools. Besides, efforts against antibiotic resistance are prominent, as evident from strict regulatory policies and huge research and developmental measures. High healthcare expenditure within the region acts as an added factor for this technological advancement in testing methodologies, thus making the region a prominent leader in the market.

As of 2023, prominent players in the Antimicrobial susceptibility testing market BioMérieux (France), Becton, Dickinson and company (US), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Bio-Rad laboratories (US) among others.

Don’t miss out on business opportunities in Antimicrobial Susceptibility Testing Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]

Antimicrobial Susceptibility Testing Market Size,  Share & Growth Report
Report Code
MD 5931
PR Published ON
11/6/2024
Choose License Type
BUY NOW
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Antimicrobial Susceptibility Testing Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status
...

Digital Virtual Assistant - MarketsandMarkets

Home